You've read 8 articles this month

TPM is funded overwhelmingly by readers’ membership fees. More than 91% of our revenue is derived from memberships and reader contributions. The rest comes from advertising. As a fully independent organization, TPM has no corporate overlords. TPM is not beholden to or controlled by any outside interests. TPM was founded by a journalist and to this day its “business” side is staffed with former journalists whose primary mission is to create a sustainable environment for our reporters and editors to do great work.

Want better media? Support a better media company

  • Reader-funded
  • Unionized
  • Mission-driven

More on Emerging Serology Surveillance

Start your day with TPM.
Sign up for the Morning Memo newsletter

Let me add a few more nuggets of information on this emerging topic.

There are a couple of important caveats and cautions about the study I flagged yesterday from Santa Clara County. One is an important possible sample bias. The way the study was conducted was people were invited to participate via Facebook. But the people responded was on a first come first serve basis. In the nature of things, people who were maybe sick in February and really wanted to know if it was COVID19 would probably be more likely to participate. So that would be a sample bias pushing the study toward a higher estimate.

Others note a more general issue, which is that these tests are not that accurate. Here I’m not talking about the particular test used in the Santa Clara County study. I’m talking about all of them at this point in their development. There’s a whole complex discussion of this in various articles, which touch on both diagnostic and statistical issues, most of it beyond my comprehension. But I think I can summarize the gist like this. Let’s say you have a test which is 95% accurate for negative results. So if you test a hundred people who have never had COVID19, 95 will come back correctly as negative but five will be falsely positive. That’s good enough to generate some valuable information if your testing a population in which the disease is prevalent. If it comes back with 65% positive, it may be a little lower or a little higher. But you know a lot of people have had it. But if you’re sampling a population where only tiny percentages are positive then quite possibly the great majority of your positives are going to be false positives.

Don’t take the precise percentages I’m using here as the actual ones. I’m trying to illustrate the concept. But given that the tests are new and in some cases have relatively high error rates this is an issue if you’re finding that 2% or 3% have positives.

Finally there’s an entirely different, very small study from Massachusetts. Researchers from Mass General went out on to the street in Chelsea, Massachusetts (a particularly hard hit town just across the river from Boston proper) and got volunteers for pinprick serology tests. They tested 200 people and 30% were positive. That is an astonishingly high percentage.

These are all small studies, under conditions with various kinds of possible sample bias and the tests themselves are new and may have high error rates. So I would not put too much stock into any individual one. It seems certain we’ll get a lot more of these data points in the coming days and over time the picture will come into focus. But 30% is really a stunning number.

Latest Editors' Blog
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Deputy Editor:
Editor at Large:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher & Digital Producer:
Senior Developer:
Senior Designer: